跳至主要内容
临床试验/NCT06867900
NCT06867900进行中(未招募)不适用

Unexplained Recurrent Pregnancy Loss: New Therapeutic Perspectives

Fondazione Policlinico Universitario Agostino Gemelli IRCCS2 个研究点 分布在 1 个国家目标入组 22 人开始时间: 2021年1月1日最近更新:
干预措施

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
22
试验地点
2
主要终点
Assessment of Endometrial inflammation in RPL women

研究概览

简要总结

Evaluation of gut permeability and endometrial inflammasome NLRP3 in women with unexplaid recurrent pregnancy loss before-after administration of Bifidobacteriumlongum ES1.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Idiopathic recurrent pregnancy loss
  • Genetic predisposition to celiac disease

排除标准

  • 未提供

研究组 & 干预措施

Bifidobacterium Longum

Experimental

干预措施: Bifidobacterium Longum ES1 (Dietary Supplement)

结局指标

主要结局

Assessment of Endometrial inflammation in RPL women

时间窗: 3 months

Analysis of the inflammasome NALP3 expression and activation in serum and endometrial fluid in women with unexplained recurrent pregnancy loss compared to women with uncomplicated pregnancy history.

Assessment of Gut permeability status in RPL women

时间窗: 3 months

Analysis of zonulin expression and activation in serum and endometrial fluid in women with unexplained recurrent pregnancy loss compared to women with uncomplicated pregnancy history.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验